Biomaterials Market By Application Analysis (Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological Disorders/Central Nervous Systems); By Type of Material Analysis (Metallic, Ceramic, Polymeric, Natural Biomaterials) and By Regional Analysis – Global Forecast by 2023-2028
The Biomaterials Market is expected to be around US$ 359 Billion by 2028 at a CAGR of 16% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
16
REPORT DESCRIPTION
Biomaterials are not new for us as they are existing from 50 years. The study relating to biomaterial is called as biomaterial science or engineering. Biomaterials may be of any kind natural or artificial / synthetic, liquid or solid that has been designed to be related with biological system for a medical reason. Biomaterials are not used directly they are used in combination with devices and implants. Biomaterials implants are the materials that can be used for betterment of lives of people who need it at the time of implant. Correct choice of biomaterial for implants is the base of a long time successful implant. No side effects should be generated in long term use and implants should function properly. The application of biomaterials is widely used in different sectors.
How Big is the Global Biomaterials Market?
The Biomaterials Market is expected to be around US$ 359 Billion by 2028 at a CAGR of 16% in the given forecast period.
The major driving factors of Biomaterials Market are as follows:
The restraining factors of Biomaterials Market are as follows:
The Biomaterials Market is segmented on the lines of its type of material, application and regional. Based on applicationsegmentation it coverscardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, neurological disorders/central nervous systems, other applications.Based on type of material segmentation it covers metallic, ceramic, polymeric, natural biomaterials.The Biomaterials Marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Biomaterials Marketand related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans Biomaterials Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets onBiomaterials Marketwith the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Covestro (Germany), Invibio Ltd. (U.K.), Carpenter Technology Corporation (U.S.), Evonik Industries AG (Germany), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Celanese Corporation (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis andcurrent developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Biomaterials Market has been segmented as below: (Accordingly)
By Application Analysis:
By Type of Material Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Biomaterials Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Biomaterials Marketdata.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Global Biomaterials Market Overview
4.2 Global Biomaterials Market, By Application
4.3 Geographic Analysis: Biomaterials Market, By Type
4.4 Geographic Snapshot: Biomaterials Market
5 Biomaterials Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increased Funds and Grants By Government Bodies for the Development of Novel Biomaterials
5.2.1.2 Increasing Demand for Implantable Devices
5.2.1.3 Growing Demand for Biomaterials in Plastic Surgery and Wound Healing Applications
5.2.1.4 Rising Number of HIP and Knee Replacement Procedures
5.2.1.5 Rising Geriatric Population and the Subsequent Growth in Incidence of Cardiovascular Diseases
5.2.1.6 Increasing Awareness About Regenerative Medicine
5.2.2 Restraints
5.2.2.1 Stringent Clinical & Regulatory Processes
5.2.2.2 Unfavorable Healthcare Reforms in the U.S.
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Market in Emerging Economies
5.2.3.2 Increasing Number of Free-Trade Agreements
5.2.4 Challenges
5.2.4.1 Limitations of Biomaterial-Based Products
6 Regulatory Assessment
6.1 Introduction
6.2 U.S.
6.2.1 Introduction
6.2.2 Fda Device Classification
6.2.3 U.S.: Regulatory Approval Timeline Assessment
6.2.4 Stringent Fda Regulations Governing Product Approvals
6.3 Europe
6.3.1 Introduction
6.3.2 European Medical Device Classification
6.3.3 Europe: Regulatory Approval Timeline Assessment
6.3.4 European Regulatory Process to Get More Stringent in Future
6.4 Japan
6.4.1 Introduction
6.4.2 PMDA Device Classification
6.4.3 Japan: Regulatory Approval Timeline Assessment
6.4.4 Revision of the Pharmaceutical Affairs Law (PAL) and Implementation of the New PMD Act in Japan
6.5 China
6.5.1 Introduction
6.5.2 CFDA Device Classification
6.5.3 China: Regulatory Approval Timeline Assessment
6.5.4 Rising Hurdles in the Regulatory Process in China
6.6 India
6.6.1 Introduction
6.6.2 India: Regulatory Approval Timeline Assessment
6.7 Australia
6.7.1 Introduction
6.7.2 TGA Device Classification
6.7.3 Australia: Regulatory Approval Timeline Assessment
7 Global Biomaterials Market, By Type of Material
7.1 Introduction
7.2 Metallic Biomaterials
7.2.1 Stainless Steel
7.2.2 Titanium & Titanium Alloys
7.2.3 Cobalt-Chrome Alloys
7.2.4 Gold
7.2.5 Silver
7.2.6 Magnesium
7.3 Ceramics
7.3.1 Calcium Phosphate
7.3.2 Zirconia
7.3.3 Aluminum Oxide
7.3.4 Calcium Sulfate
7.3.5 Carbon
7.3.6 Glass
7.4 Polymers
7.4.1 Polymethylmethacrylate (PMMA)
7.4.2 Polyethylene
7.4.3 Polyester
7.4.4 Polyvinylchloride (PVC)
7.4.5 Silicone Rubber
7.4.6 Nylon
7.4.7 Polyetheretherketone (PEEK)
7.4.8 Polylactic Acid, Poly Glycolic Acid, and Poly(Lactide-Co-Glycolide)
7.4.9 Other Polymers
7.5 Natural Biomaterials
7.5.1 Hyaluronic Acid
7.5.2 Collagen
7.5.3 Gelatin
7.5.4 Fibrin
7.5.5 Cellulose
7.5.6 Chitin
7.5.7 Alginates
7.5.8 Silk
8 Biomaterials Market, By Application
8.1 Introduction
8.2 Cardiovascular
8.2.1 Catheters
8.2.2 Stents
8.2.3 Implantable Cardiac Defibrillators
8.2.4 Pacemakers
8.2.5 Sensors
8.2.6 Heart Valves
8.2.7 Vascular Grafts
8.2.8 Guidewires
8.2.9 Others
8.3 Orthopedic
8.3.1 Joint Replacement
8.3.1.1 Knee Replacement
8.3.1.2 HIP Replacement
8.3.1.3 Shoulder Replacement
8.3.1.4 Others
8.3.2 Viscosupplementation
8.3.3 Bioresorbable Tissue Fixation
8.3.3.1 Suture Anchors
8.3.3.2 Interference Screws
8.3.3.3 Meniscal Repair Tacks
8.3.3.4 Meshes
8.3.4 Spine
8.3.4.1 Spinal Fusion
8.3.4.2 Minimally Invasive Fusion Surgeries
8.3.4.3 Motion Preservation & Dynamic Stabilization
8.3.4.3.1 Pedicle-Based Rod Systems
8.3.4.3.2 Interspinous Spacers
8.3.4.3.3 Disc Arthroplasty/Replacement
8.3.5 Fracture Fixation
8.3.5.1 Bone Plates
8.3.5.2 Screws
8.3.5.3 Pins
8.3.5.4 Rods
8.3.5.5 Wires
8.3.6 Orthobiologics
8.3.6.1 Synthetics Bone Grafts
8.4 Ophthalmology
8.4.1 Contact Lenses
8.4.2 Intraocular Lenses
8.4.3 Functional Replacement of Ocular Tissues
8.4.4 Synthetic Corneas
8.4.5 Others
8.5 Dental
8.5.1 Dental Implants
8.5.2 Dental Bone Grafts & Substitutes
8.5.3 Dental Membranes
8.5.4 Tissue Regeneration
8.6 Plastic Surgery
8.6.1 Soft Tissue Fillers
8.6.2 Craniofacial Surgery
8.7 Wound Healing
8.7.1 Wound Closure Devices
8.7.1.1 Sutures
8.7.1.2 Staples
8.7.2 Surgical Hemostats
8.7.3 Internal Tissue Sealants
8.7.4 Adhesion Barriers
8.7.5 Hernia Meshes
8.8 Tissue Engineering
8.8.1 Scaffolds for Regenerative Medicine
8.8.2 Nanomaterials for Biosensing
8.8.3 Tailoring of Inorganic Nanoparticles
8.9 Neurological/Central Nervous System
8.9.1 Shunting Systems
8.9.2 Cortical Neural Prosthetics (CNP)
8.9.3 Hydrogel Scaffolds for CNS Repair
8.9.4 Neural Stem Cell Encapsulation
8.10 Other Applications
8.10.1 Drug Delivery Systems
8.10.2 Gastrointestinal Applications
8.10.3 Bariatric Surgery
8.10.4 Urinary Applications
9 Global Biomaterials Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Biomaterials-Based Research in the U.S.
9.2.1.2 Growing Demand for Plastic Surgeries in the U.S.
9.2.1.3 Conferences and Symposiums on Biomaterials in the U.S.
9.2.1.4 Increase in Cancer Incidence
9.2.1.5 Growing Prevalence of Cardiovascular Diseases
9.2.2 Canada
9.2.2.1 Increasing R&D Activities for Biomaterials in Canada
9.2.2.2 Growth in Geriatric Population in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Rising Cases of HIP and Knee Replacements
9.3.1.2 Growing Medical Devices Industry in Germany
9.3.2 U.K.
9.3.2.1 Availability of Funds and Grants
9.3.2.2 Rise in Cvd Prevalence in the U.K.
9.3.2.3 Conferences & Annual Meetings
9.3.2.4 Rising Volume of Cosmetic Surgeries in the U.K.
9.3.3 France
9.3.3.1 Favorable Government Support, Growth in Aging Population
9.3.4 Spain
9.3.4.1 Increasing Research Activities on Biomaterials
9.3.5 Rest of Europe (RoE)
9.3.5.1 Improving Healthcare Structure in Russia
9.3.5.2 RoE: Rising Geriatric Population
9.3.5.3 Turkey: Growth in the Healthcare Sector, Rising Medical Tourism
9.4 Asia-Pacific
9.4.1 International Alliances
9.4.2 Japan
9.4.2.1 Japan’s Growing Healthcare Industry
9.4.3 China
9.4.3.1 Lucrative Medical Devices Industry in China
9.4.3.2 China’s Favorable Tax Policy
9.4.3.3 Growing Aging Population
9.4.4 India
9.4.4.1 India: A Hotspot for Cosmetic and Plastic Surgery
9.4.4.2 High Incidence of Cardiovascular Diseases
9.4.4.3 Increasing Geriatric Population
9.4.5 Rest of Asia-Pacific (RoAPAC)
9.4.5.1 Rising Volume of HIP and Knee Replacement Procedures in Australia
9.4.5.2 Indonesia: Regulations Hindering Market Growth
9.4.5.3 Increasing Research in Australia, Singapore, and Hong Kong
9.5 Rest of the World (RoW)
9.5.1 Middle East: Increasing Geriatric Population, Rise in Age-Related Disorders
9.5.2 High Prevalence of Obesity in Latin America
9.5.3 Opportunities in the Brazilian Market
9.5.4 Increasing Aging Population, Growing Cardiovascular Disease Prevalence in Brazil
9.5.5 Market Scenario in Latin America and South Africa
10 Competitive Landscape
10.1 Overview
10.2 Comparative Assessment of Key Players in the Biomaterials Market (2013–2016)
10.3 Competitive Scenario
10.4 Agreements, Collaborations, Partnerships, and Joint Ventures
10.4.1 Product Launches
10.4.2 Mergers and Acquisitions
10.4.3 Expansions
10.4.4 Other Strategies
11 Company Profiles
11.1 Introduction
11.2 Royal DSM
11.3 BASF SE
11.4 Corbion N.V.
11.5 Covestro (Subsidiary of Bayer Ag)
11.6 Invibio Ltd. (Subsidiary of Victrex PLC)
11.7 Carpenter Technology Corporation
11.8 Evonik Industries AG
11.9 Berkeley Advanced Biomaterails, Inc.
11.10 Cam Bioceramics Bv
11.11 Celanese Corporation
The Biomaterials Market has been segmented as below: (Accordingly)
By Application Analysis:
By Type of Material Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE